Comparison of the long-term risk of recurrence and other clinical outcomes in GIST patients receiving imatinib as adjuvant therapy--a retrospective chart extract-based approach

J Gastrointest Cancer. 2013 Jun;44(2):190-8

View abstract

Authors

Conley AP, Guerin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ